Correlation Between IShares Biotechnology and Invesco DWA

Can any of the company-specific risk be diversified away by investing in both IShares Biotechnology and Invesco DWA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Biotechnology and Invesco DWA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Biotechnology ETF and Invesco DWA Healthcare, you can compare the effects of market volatilities on IShares Biotechnology and Invesco DWA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Biotechnology with a short position of Invesco DWA. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Biotechnology and Invesco DWA.

Diversification Opportunities for IShares Biotechnology and Invesco DWA

0.78

Correlation Coefficient

IShares Biotechnology  Invesco DWA

Poor diversification

The 3 months correlation between IShares and Invesco is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding iShares Biotechnology ETF and Invesco DWA Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco DWA Healthcare and IShares Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Biotechnology ETF are associated (or correlated) with Invesco DWA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco DWA Healthcare has no effect on the direction of IShares Biotechnology i.e., IShares Biotechnology and Invesco DWA go up and down completely randomly.

Pair Corralation between IShares Biotechnology and Invesco DWA

Considering the 90-day investment horizon iShares Biotechnology ETF is expected to generate 0.82 times more return on investment than Invesco DWA. However, iShares Biotechnology ETF is 1.22 times less risky than Invesco DWA. It trades about -0.1 of its potential returns per unit of risk. Invesco DWA Healthcare is currently generating about -0.12 per unit of risk. If you would invest  14,789  in iShares Biotechnology ETF on September 16, 2024 and sell it today you would lose (1,128) from holding iShares Biotechnology ETF or give up 7.63% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

iShares Biotechnology ETF  vs.  Invesco DWA Healthcare

iShares Biotechnology ETF

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares Biotechnology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Etf's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Invesco DWA Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Invesco DWA Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

Pair Trading with IShares Biotechnology and Invesco DWA

The main advantage of trading using opposite IShares Biotechnology and Invesco DWA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Biotechnology position performs unexpectedly, Invesco DWA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco DWA will offset losses from the drop in Invesco DWA's long position.

The idea behind iShares Biotechnology ETF and Invesco DWA Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.